Apogee Biologics, Inc.
Records under this name other than patents Apogee Biologics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Apogee Biologics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 12,358,979 | Antibodies That Bind Interleukin 13 and Methods of Use merged into Apogee Therapeutics, Inc. In force · High confidence | In force | High confidence | |
| 19/157,017 | Antibodies That Bind Interleukin 4 Receptor Alpha and Methods of Use merged into Apogee Therapeutics Inc. - now held by Apogee Therapeutics, Inc. Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 19/234,011 | Antibodies That Bind Interleukin 13 and Methods of Use merged into Apogee Therapeutics, Inc. Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 19/425,386 | Antibodies That Bind OX40L and Methods of Use merged into Apogee Therapeutics, Inc. Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 19/425,771 | Antibodies That Bind Interleukin 4 Receptor Alpha and Methods of Use merged into Apogee Therapeutics, Inc. Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. |